Implementation of Personalized Precision Medicine. Expanding the Clinical Vision towards Prevention, Early Detection and Precision Treatment of Disease to Drive Extended Healthspan

Authors

William P. Stanford Chief Medical Officer, Beverly Hills Institute for Precision Medicine, , Beverly Hills, CA, USA. Dr Stanford MD, PhD is a physician-scientist and Fellow of the American College of Physicians. He is one of the pioneers in the field of hospital medicine. In 2002, he founded and led a 25-physician group of private practice hospitalists at Cedars-Sinai Medical Center. From 2001-2018, he was the physician of record for over 150,000 patient encounters. He was elected by his peers to be Clinical Chief of General Internal Medicine, serving in this capacity from 2017 to 2018. Advances in genomics and precision medicine inspired him to pivot again, this time to precision medicine. He completed Professional Certification in Genetics and Genomics through Stanford University in 2018. In 2018, he founded the Beverly Hills Institute for Precision Medicine and continues to present as the Chief Medical and Scientific Officer. He regularly attends and frequently speaks at precision medicine conferences, most recently at the Precision Medicine World Conference in January of 2020 Laura Kelly Chief Science Officer, Opal Health Los Angeles, California, USA. Laura Kelly DAOM, MATCM, L. Ac, Dipl. OM is a nationally licensed Doctor of Oriental Medicine. She is in general practice in Los Angeles with a focus on resolving chronic disease through personalized precision medicine. This practice has expanded to include telemedicine consults with patients throughout the US as well as consults for practicing physicians on the use of genomics and nutrition in chronic disease resolution. In 2019 she founded Opal Health where she is currently CEO and CSO, creating precision prevention tools for corporate implementation as well as for the general public.